Nav: Home

Immunotherapy and diabetes: A game of hide and seek?

June 11, 2019

Osaka, Japan - Immune checkpoint inhibitors (ICIs) are an emerging type of cancer immunotherapy that uses the immune system to attack cancer cells. However, in some patients they cause the immune system to attack healthy cells, leading to autoimmune diseases. When pancreatic beta cells are attacked, this can lead to type 1 diabetes. In a case report published in Diabetes Care, researchers from Osaka University provide insight into this unintended consequence of ICIs.

Type 1 diabetes is caused by the destruction of pancreatic beta cells, which produce insulin. Recent clinical studies in patients with cancer have found that ICIs can in rare cases lead to this form of diabetes. Exactly how ICIs might do this, though, is a mystery.

The researchers came across a singular circumstance in a patient with kidney cancer who was treated with ICIs. The situation allowed them to examine tissue stains and take a closer look at the disease. "The patient's cancer had metastasized and spread to his pancreas, which had to be removed," lead author Sho Yoneda explains.

When the team looked at the pancreas, they found the hallmark signs of type 1 diabetes. "We saw substantial infiltration of T cells into the pancreatic tissue and very few surviving beta cells," Yoneda continues. "What was interesting was that the remaining beta cells had little or no expression of the immune tolerance protein PD-L1. This was unexpected, because previous studies had reported elevated PD-L1 in the beta cells of patients with typical autoimmune type 1 diabetes."

PD-L1 tells the immune system that a cell is not a foreign threat. This process, called immune tolerance, stops the immune system from attacking vital tissues and organs--like the pancreas.

"ICIs block the effect of proteins like PD-L1 and essentially shut down immune tolerance," says Iichiro Shimomura, professor at Osaka University and co-author of the study. "This is excellent for treating cancer because tumors often express PD-L1, which allows them to hide from the immune system. The problem is that by shutting down immune tolerance, you increase the likelihood that the immune system will also start to attack healthy tissue."

It remains unclear whether ICIs caused the observed damage to the patient's pancreas, and the role played by PD-L1 is still unclear. "There is still a great deal to be learned about how checkpoint inhibitors contribute to autoimmune diseases," Shimomura adds. "Still, this case suggests that therapies targeting PD-L1 may cause cellular changes that can ultimately lead to type 1 diabetes."
-end-
The article, "T-Lymphocyte Infiltration to Islets in the Pancreas of a Patient Who Developed Type 1 Diabetes After Administration of Immune Checkpoint Inhibitors," was published in Diabetes Care at DOI: 10.2337/dc18-2518.

Osaka University

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
More Diabetes News and Diabetes Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Risk
Why do we revere risk-takers, even when their actions terrify us? Why are some better at taking risks than others? This hour, TED speakers explore the alluring, dangerous, and calculated sides of risk. Guests include professional rock climber Alex Honnold, economist Mariana Mazzucato, psychology researcher Kashfia Rahman, structural engineer and bridge designer Ian Firth, and risk intelligence expert Dylan Evans.
Now Playing: Science for the People

#541 Wayfinding
These days when we want to know where we are or how to get where we want to go, most of us will pull out a smart phone with a built-in GPS and map app. Some of us old timers might still use an old school paper map from time to time. But we didn't always used to lean so heavily on maps and technology, and in some remote places of the world some people still navigate and wayfind their way without the aid of these tools... and in some cases do better without them. This week, host Rachelle Saunders...
Now Playing: Radiolab

Dolly Parton's America: Neon Moss
Today on Radiolab, we're bringing you the fourth episode of Jad's special series, Dolly Parton's America. In this episode, Jad goes back up the mountain to visit Dolly's actual Tennessee mountain home, where she tells stories about her first trips out of the holler. Back on the mountaintop, standing under the rain by the Little Pigeon River, the trip triggers memories of Jad's first visit to his father's childhood home, and opens the gateway to dizzying stories of music and migration. Support Radiolab today at Radiolab.org/donate.